Rutter J J - OmicsDI

Show results for

Unknown (416)
Proteomics (24)
Transcriptomics (6)
Metabolomics (5)

Organisms

Homo sapiens (17)
Mus musculus (10)
Rattus norvegicus (2)
Saccharomyces cerevisiae (2)
Danio rerio (1)
Onchocerca ochengi (1)

Repository

pride (24)
biostudies-arrayexpress (7)
MetaboLights (5)

Tissue

Cell culture (12)
Type B pancreatic cell (2)
Blood (1)
Heart (1)
Hepatocyte (1)
Kidney (1)
Kidney proximal convoluted tubule epithelial cell (1)
Liver (1)
Permanent cell line cell (1)
T cell (1)
Whole body (1)

Disease

Type 2 diabetes mellitus (2)
Prostate cancer (1)
Cardiovascular system (1)
Cardiovascular system disease (1)
Non-alcoholic steatohepatitis (1)

Technology Type

Mass Spectrometry (24)
Data-dependent acquisition (7)
Shotgun proteomics (6)
Mass spectrometry (4)
Data-independent acquisition (4)
Bottom-up proteomics (3)
Affinity purification coupled with mass spectrometry proteomics (2)
Gel-based experiment (2)
Top-down proteomics (2)
Mass spectrometry assay (1)
Affinity proteomics (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
DiaPASEF (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (3)
Liquid Chromatography MS - positive - reverse phase (3)
Illumina HiSeq 2000 (2)
G2565AA DNA microarray scanner [Agilent] (1)
Illumina HiSeq 4000 (1)
Direct infusion MS - negative (1)
Direct infusion MS - positive (1)
Flow injection analysis MS - negative (1)
Flow injection analysis MS - positive (1)
Liquid Chromatography MS - Alternating (LC-MS (Alternating)) (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2026 (9)
2024 (5)
2023 (4)
2025 (4)
2019 (2)
2022 (2)
2021 (2)
2020 (2)
2018 (1)
2017 (1)
2016 (1)
2014 (1)
2013 (1)
2009 (1)

CHEBI ID

CHEBI:12962 (2)
CHEBI:15318 (2)
CHEBI:15346 (2)
CHEBI:15351 (2)
CHEBI:15354 (2)
CHEBI:15355 (2)
CHEBI:15380 (2)
CHEBI:15422 (2)
CHEBI:15539 (2)
CHEBI:15611 (2)
CHEBI:15698 (2)
CHEBI:15713 (2)
CHEBI:15721 (2)
CHEBI:15729 (2)
CHEBI:15741 (2)
CHEBI:15753 (2)
CHEBI:15760 (2)
CHEBI:15784 (2)
CHEBI:15811 (2)
CHEBI:15842 (2)
CHEBI:15918 (2)
CHEBI:15978 (2)
CHEBI:15996 (2)
CHEBI:16015 (2)
CHEBI:16108 (2)
CHEBI:16264 (2)
CHEBI:16284 (2)
CHEBI:16311 (2)
CHEBI:16335 (2)
CHEBI:16436 (2)

Metabolite Name

CDP-ethanolamine (2)
DUTP (2)
(3S)-3-hydroxy-3-methylglutaryl-CoA (1)
(4R)-4-Hydroxy-L-glutamic acid (1)
(N(omega)-L-arginino)succinic acid (1)
(R)-3-(4-hydroxyphenyl)lactic acid (1)
(R)-3-Hydroxybutyric acid (1)
(S)-3-Hydroxybutyric acid (1)
1,3-Diaminopropane (1)
1-Methyl-L-histidine (1)
1-Methylhistamine (1)
1-Methylnicotinamide (1)
2'-deoxyadenosine 5'-monophosphate (1)
2'-deoxycytidine (1)
2'-deoxycytosine 5'-monophosphate (1)
2'-deoxyguanosine (1)
2'-deoxyguanosine 3'-monophosphate (1)
2'-deoxyuridine (1)
2,3-Dihydroxypropanoic acid (1)
2,3-Dihydroxypropyl hexopyranoside (1)
2,3-Diphospho-D-glyceric acid (1)
2,3-Pyridinedicarboxylic acid (1)
2,5-Dihydroxybenzaldehyde (1)
2,5-Dihydroxybenzoic acid (1)
2-(Hydroxymethyl)butanoic acid (1)
2-Amino-3-methoxybenzoic acid (1)
2-Aminoadipic acid (1)
2-Deoxy-5-cytidylic acid (1)
2-Deoxy-D-ribonic acid (1)
2-Deoxy-D-ribose (1)

Study type

RNA-seq of coding RNA (3)
Transcription profiling by array (2)
Cell line - High-throughput sequencing (1)

Release Date

2024 (58)
2025 (51)
2023 (48)
2019 (43)
2020 (41)
2022 (37)
2021 (29)
2018 (19)
2017 (17)
2016 (15)
2015 (11)
2014 (9)
2012 (7)
2010 (6)
2013 (5)
2009 (5)
2026 (5)
2011 (5)
2007 (5)
2008 (2)
2005 (2)
2006 (1)
2003 (1)
2001 (1)

Lab affiliation

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (10)
Biological Chemistry and Molecular Pharmacology, Harvard Medical School Cancer Biology, Dana-Farber Cancer Institute (1)
CVRTI, University of Utah (1)
Center for Molecular Medicine, University Medical Center Utrecht, 3584 Utrecht, the Netherlands. (1)
Dana Farber Cancer Institute (1)
Department of Biochemistry, The University of Utah, Salt Lake City, UT, USA Howard Hughes Medical Institute, University of Utah, Salt Lake City, UT, USA (1)
Department of Cell Biology, Harvard Medical School, Boston, MA, USA (1)
Department of Nutrition and Integrative Physiology, College of Health, University of Utah, UT 84112, USA Diabetes and Metabolism Research Center, University of Utah, UT 84112, USA (1)
Division of Metabolism, Endocriology & Diabetes and Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48105, USA (1)
Dr. Sarah Franklin, Principal Investigator, CVRTI, University of Utah (1)
Facility - Proteomics & Metabolomics (1)
Harvard Medical School, Department of Cell Biology Howard Hughes Medical Institute (1)
MRC-Laboratory of Medical Sciences (1)
Medical School, Department of Biochemistry, University of Utah, Salt Lake City, USA (1)
Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool UK (1)

Previous page
1 / 46
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 46
Next page

Sort by:

Relevance

Page size

Nurse navigators in early cancer care: a randomized, controlled trial.

Not available

S-EPMC3867643 | biostudies-literature

Phosphate Starvation Signaling Increases Mitochondrial Membrane Potential through Respiration-independent Mechanisms

The mitochondrial membrane potential directly powers many critical functions of mitochondria, including ATP production, mitochondrial protein import, and metabolite transport. Its loss is a cardinal feature of aging and mitochondrial diseases, and cells closely monitor membrane potential as an indic...

ORGANISM(S): Saccharomyces cerevisiae (Baker's yeast)

2024-02-15 | PXD037405 | Pride

Mitochondria Phosphate

The biochemical basis of mitochondrial dysfunction in Zellweger Spectrum Disorder

We identified that peroxins were still expressed in Zellweger Spectrum Disorder (ZSD) and a subset of them accumulated on the mitochondrial membrane, which resulted in gross mitochondrial abnormalities and impaired mitochondrial metabolic function. In this complexome analysis we detected several per...

ORGANISM(S): Saccharomyces cerevisiae (Baker's yeast)

2021-06-25 | PXD024625 | Pride

Peroxisomes Mitocondrial quality control Mitochondria Peroxisomal biogenesis disorder Peroxisomal import Lc-msms Complexome profiling

Evidence of altered fatty acid metabolism in dogs with naturally occurring valvular heart disease and congestive heart failure

INTRODUCTION: Myxomatous mitral valve disease (MMVD) is the most common cardiac condition in adult dogs. The disease progresses over several years and affected dogs may develop congestive heart failure (HF). Research has shown that myocardial metabolism is altered in cardiac dise...

2022-03-31 | MTBLS716 | MetaboLights

Impact of Mitochondrial Fatty Acid Synthesis on Mitochondrial Biogenesis.

Not available

S-EPMC6258005 | biostudies-literature

Activation of PASK by mTORC1 is required for the onset of the terminal differentiation program.

Not available

S-EPMC6534978 | biostudies-literature

EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma.

Not available

S-EPMC5668171 | biostudies-literature

PAS kinase drives lipogenesis through SREBP-1 maturation.

Not available